Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial.
Hueb W, Gersh BJ, Rezende PC, Garzillo CL, Lima EG, Vieira RD, Garcia RM, Favarato D, Segre CA, Pereira AC, Soares PR, Ribeiro E, Lemos P, Perin MA, Strunz CC, Dallan LA, Jatene FB, Stolf NA, Hueb AC, Dias R, Gaiotto FA, da Costa LM, Oikawa FT, de Melo RM, Serrano CV Jr, de Ávila LF, Villa AV, Filho JR, Nomura C, Ramires JA, Kalil Filho R; MASS-V Study Group.
Hueb W, et al.
BMC Cardiovasc Disord. 2012 Aug 16;12:65. doi: 10.1186/1471-2261-12-65.
BMC Cardiovasc Disord. 2012.
PMID: 22898311
Free PMC article.
Clinical Trial.